Observed Signal · Oct 22, 2026 · earnings · Source: SEC API · Impact: 3.8/5
10-Q Financial Filing Analysis for P&G (2026-10-22)
For the first fiscal quarter ended September 30, 2026, The Procter & Gamble Company reported consolidated net sales of $23.28 billion, up 4.0% year-over-year, driven by a 2.4% unit volume increase, 1.1% positive geographic mix, and 0.4% higher pricing. Operating income rose 1.4% to $5.94 billion, while gross margin contracted 160 basis points to 49.8% due to higher commodity costs and product/packaging investments, partially offset by manufacturing productivity gains. Net earnings attributable to P&G declined marginally to $4.73 billion, while diluted EPS increased 1% to $1.97 (Core EPS rose 1% to $2.00). Operating cash flow reached $5.77 billion with free cash flow of $4.40 billion, demonstrating solid 93% free cash flow productivity. Subsequent to quarter-end on October 1, 2026, P&G completed the $3.9 billion all-cash acquisition of premium wellness brand Thorne. The company also progressed its two-year $2.0 billion portfolio and productivity restructuring plan, which aims to reduce up to 7,000 non-manufacturing personnel by the end of fiscal 2027.
P&G demonstrates resilient volume-led organic growth amid commodity cost pressures, backed by disciplined capital allocation through a $3.9 billion bolt-on acquisition and aggressive multi-year restructuring to reduce overhead.
Track P&G Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Net sales rose 4.0% year-over-year to $23.28 billion, supported by 2.4% volume growth and 4.0% organic sales growth.
- Gross margin compressed by 160 basis points to 49.8%, impacted by commodity headwinds and packaging investments, though buffered by SG&A leverage to deliver $5.94 billion in operating income.
- Closed the $3.9 billion all-cash acquisition of wellness supplement maker Thorne on October 1, 2026, integrating it into Personal Health Care.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
10-K Financial Filing Analysis for P&G (2026-08-04)
Procter & Gamble (P&G) reported its full-year financial results for the fiscal year ended June 30, 2026. Consolidated net sales increased 3% year-over-year to $87.03 billion, supported by 1% organic sales growth and a 2% favorable foreign exchange impact. Operating income decreased 3% to $19.75 billion due to a 100-basis-point decline in gross margin to 50.2% and higher marketing spending in SG&A. Net earnings rose slightly to $16.14 billion ($16.05 billion attributable to P&G), with diluted EPS improving 2% to $6.62, aided by share repurchases and non-operating gains including $261 million from the expiration and dissolution of the Glad joint venture interest. Operating cash flow remained strong at $19.56 billion, supporting $15.84 billion in adjusted free cash flow (100% productivity). The company continued executing its multi-year portfolio and productivity plan, incurring $903 million after tax in restructuring costs in fiscal 2026. P&G also announced an agreement on August 4, 2026, to acquire premium supplement brand Thorne for $3.8 billion.
10-K Financial Filing Analysis for Pampers (2026-08-04)
The Procter & Gamble Company reported its annual results for the fiscal year ended June 30, 2026, delivering net sales of $87.03 billion, up 3% year-over-year, supported by organic sales growth of 1%. Operating income decreased 3% to $19.75 billion due to a 100 bps reduction in gross margin (to 50.2%) driven by unfavorable product mix, increased commodity costs, and restructuring charges, alongside higher marketing expenditures. Net earnings attributable to P&G remained stable at $16.05 billion, with diluted EPS rising 2% to $6.62, aided by share repurchases and lower net non-operating costs. Cash generation remained robust, with operating cash flow reaching $19.56 billion and adjusted free cash flow productivity achieving 100%. Strategically, P&G continued executing its multi-year productivity and organizational restructuring program while expanding its portfolio, notably announcing the acquisition of Thorne for $3.8 billion.
10-Q Financial Filing Analysis for Colgate-Palmolive (2026-10-30)
Colgate-Palmolive reported solid Q3 2026 financial results, with net sales increasing 4.6% year-over-year to $5,369 million, driven by 1.7% volume growth, 2.0% pricing gains, and a 1.0% foreign exchange tailwind. Organic sales grew 3.6%, bolstered by strength in Latin America (+6.0%) and Hill's Pet Nutrition (+5.7%), offsetting a 1.6% organic sales decline in North America. Operating profit rose 2.7% to $1,088 million, while diluted EPS increased to $0.94 ($0.97 non-GAAP), supported by gross margin expansion of 80 bps to 60.2% through funding-the-growth cost savings. Operating performance absorbed $30 million of pre-tax restructuring charges in Q3 ($333 million year-to-date) associated with the Strategic Growth and Productivity Program, which targets $200–$300 million in annualized pre-tax savings by 2028. Free cash flow generation remained strong, with nine-month operating cash flows increasing 6.1% to $2,913 million. Despite continued raw material inflation and macroeconomic softness, the company sustained market leadership, maintaining a 41.4% global toothpaste market share.
Receive all future signals for P&G & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.